News-Medical.Net on MSN10d
Targeting PCSK9 and APOA4 for the treatment of TMAO-induced cholelithiasis
Cholesterol synthesis and gallstone formation are promoted by trimethylamine-N-oxide (TMAO), a derivative of trimethylamine, ...
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
Novel ferritin-based siRNA delivery system shows promise for targeted glioblastoma therapy
In vitro experiments showed that tHFn(+) efficiently delivered siRNA into the cytoplasm, resulting in effective gene ...